Shionogi & Co Ltd (SGIOF) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Shionogi & Co., Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.972 -- 00:00:03.972 Ladies 00:00:06.403 -- 00:00:08.930 and gentlemen, time to start today's meeting. 00:00:08.930 -- 00:00:14.424 I am Kyokawa, the head of Public Relations Department at Shio Nuki & Company. 00:00:14.424 -- 00:00:17.834 Thank you very much for taking time to join us today. 00:00:17.834 -- 00:00:23.181 We will now begin the CEO Nogi and Company Limited's second quarter financial 00:00:23.181 -- 00:00:28.568 results briefing for fiscal year 2024. First of all, let me introduce 00:00:28.568 -- 00:00:31.813 the speakers for today. This is 00:00:31.813 -- 00:00:35.318 Isao Teshiyogi, Chairman, President, and CEO. 00:00:35.318 -- 00:00:37.100 And next, 00:00:37.100 -- 00:00:41.826 Mr. John Keller, Senior Vice President, R&D Supervisory Unit. 00:00:41.826 -- 00:00:47.333 Very nice to see you. Next, Mr. Toshinobu Iwasaki, Senior Vice President, 00:00:47.333 -- 00:00:51.839 Healthcare Business Unit. I am Iwasaki. Very nice to see you. 00:00:51.839 -- 00:00:53.941 And then next, 00:00:53.941 -- 00:00:59.088 Mr. Goji Hanazaki, Senior Vice President, Supply Supervisory Unit, Global 00:00:59.088 -- 00:01:03.974 Business Division. Very nice to see you. Next, Mr. 00:01:03.974 -- 00:01:08.898 Takeki Uehara, Senior Vice President, Drug Development and Regulatory Science Division. 00:01:08.898 -- 00:01:14.068 Nice to see you. Lastly, Ms. Masako Kuro, Vice President, Finance 00:01:14.068 -- 00:01:19.257 and Accounting Department. Today, we'll begin with the overview of the financial result, 00:01:19.257 -- 00:01:24.227 followed by the presentation of initiatives for achieving 2030 vision given by Mr. 00:01:24.227 -- 00:01:26.852 Teshioki, Mr. John Keller, Mr. Uehara, and Mr. 00:01:26.852 -- 00:01:31.240 Iwasaki in this order. We will then take question...